Pfizer Submits Application to Swiss Authorities for COVID-19 Booster in Children Aged 5–11
Pfizer
Pharmaceutical R&D Developer
Swissmedic
Swissmedic is a federal agency governed by the Federal Act on Therapeutic Products and Medical Devices. The agency is independent in terms of organization and management, with 300 full-time employees.
On May 31, according to the report of Cailian News, the Swiss Medicines Agency stated that the local department of Pfizer Inc. had submitted an application to obtain approval for the sale of a booster shot of the COVID-19 vaccine in children aged 5-11. The Swiss Medicines Agency said it is evaluating the benefits and risks of the dose recommendations for children based on the submitted data. It is reported that the concentration of the vaccine for children is lower (10 micrograms), with an injection volume of 0.25 milliliters, which is four times lower than that for adults.
*Disclaimer: This article was written by an author who has settled in Sina Medicine News. The views expressed represent the personal opinions of the author and do not reflect the position of Sina Medicine News.